TRAPPC2
Basic information
Region (hg38): X:13712244-13734635
Previous symbols: [ "SEDL" ]
Links
Phenotypes
GenCC
Source:
- spondyloepiphyseal dysplasia tarda, X-linked (Strong), mode of inheritance: XL
- spondyloepiphyseal dysplasia tarda (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spondyloepiphyseal dysplasia tarda, X-linked | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 10431248; 14755465; 15316971; 19002213; 19417549; 19766614; 20301324; 22563562; 23656395 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (10 variants)
- Spondyloepiphyseal dysplasia tarda (5 variants)
- Spondyloepiphyseal dysplasia tarda, X-linked (3 variants)
- Hereditary spastic paraplegia 4 (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRAPPC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 12 | 16 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 12 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 1 | 4 | 3 | 8 | ||
non coding | 31 | 15 | 28 | 74 | ||
Total | 12 | 7 | 47 | 20 | 34 |
Variants in TRAPPC2
This is a list of pathogenic ClinVar variants found in the TRAPPC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-13712297-T-TCA | Spondyloepiphyseal dysplasia congenita | Benign (Jun 14, 2016) | ||
X-13712347-C-T | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Jan 12, 2018) | ||
X-13712372-G-A | Spondyloepiphyseal dysplasia tarda | Benign (Jan 13, 2018) | ||
X-13712444-T-C | Spondyloepiphyseal dysplasia tarda | Benign (Jan 12, 2018) | ||
X-13712558-A-AT | Spondyloepiphyseal dysplasia congenita | Likely benign (Jun 14, 2016) | ||
X-13712668-G-C | Spondyloepiphyseal dysplasia tarda | Benign (Apr 27, 2017) | ||
X-13712773-C-A | Spondyloepiphyseal dysplasia tarda | Benign (Jan 12, 2018) | ||
X-13712808-A-G | Spondyloepiphyseal dysplasia tarda | Benign (Jan 13, 2018) | ||
X-13712921-C-T | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Jan 12, 2018) | ||
X-13712964-C-T | Spondyloepiphyseal dysplasia tarda | Benign (Jan 12, 2018) | ||
X-13712965-G-A | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Jan 13, 2018) | ||
X-13712971-G-A | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Jan 12, 2018) | ||
X-13712971-G-C | Spondyloepiphyseal dysplasia tarda | Benign (Jan 12, 2018) | ||
X-13713103-CA-C | Spondyloepiphyseal dysplasia congenita | Benign (Jun 14, 2016) | ||
X-13713119-A-C | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Jan 12, 2018) | ||
X-13713120-C-A | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Apr 27, 2017) | ||
X-13713178-G-A | Spondyloepiphyseal dysplasia tarda | Likely benign (Apr 27, 2017) | ||
X-13713216-G-A | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Jan 12, 2018) | ||
X-13713279-G-A | Spondyloepiphyseal dysplasia tarda | Benign (Jan 12, 2018) | ||
X-13713355-A-G | Spondyloepiphyseal dysplasia tarda | Benign (Apr 27, 2017) | ||
X-13713357-G-A | Spondyloepiphyseal dysplasia tarda | Likely benign (Apr 27, 2017) | ||
X-13713375-A-G | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Jan 13, 2018) | ||
X-13713418-C-A | Spondyloepiphyseal dysplasia tarda | Uncertain significance (Jan 12, 2018) | ||
X-13713449-T-TAAAAAAA | Spondyloepiphyseal dysplasia congenita | Uncertain significance (Jun 14, 2016) | ||
X-13713450-C-CA | Spondyloepiphyseal dysplasia congenita | Uncertain significance (Jun 14, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRAPPC2 | protein_coding | protein_coding | ENST00000458511 | 5 | 22392 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00241 | 0.557 | 115758 | 0 | 2 | 115760 | 0.00000864 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.53 | 24 | 56.4 | 0.426 | 0.00000404 | 1169 |
Missense in Polyphen | 4 | 13.921 | 0.28734 | 333 | ||
Synonymous | -0.429 | 24 | 21.5 | 1.12 | 0.00000178 | 290 |
Loss of Function | 0.275 | 4 | 4.64 | 0.862 | 3.36e-7 | 95 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000813 | 0.0000585 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000141 | 0.00000964 |
Middle Eastern | 0.0000813 | 0.0000585 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Prevents transcriptional repression and induction of cell death by ENO1 (By similarity). May play a role in vesicular transport from endoplasmic reticulum to Golgi. {ECO:0000250}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Rab regulation of trafficking;RAB GEFs exchange GTP for GDP on RABs;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.355
Intolerance Scores
- loftool
- rvis_EVS
- 0.12
- rvis_percentile_EVS
- 62.38
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.469
- ghis
- 0.624
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.824
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Trappc2
- Phenotype
- reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- skeletal system development;regulation of transcription, DNA-templated;endoplasmic reticulum to Golgi vesicle-mediated transport;COPII vesicle coating
- Cellular component
- Golgi membrane;nucleus;nucleoplasm;endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment;cytosol;TRAPP complex;intracellular membrane-bounded organelle;perinuclear region of cytoplasm
- Molecular function
- protein binding;transcription factor binding;Rab guanyl-nucleotide exchange factor activity;ion channel binding